Biotechnology improves our ability to measure disease processes more precisely and helps to customize patient-specific strategies based on individual genes and proteins so as to better predict, prevent, diagnose, and treat subtypes of disease rather than using the "one-size-fits-all" approach.
These developments have boosted progress in the discovery of susceptibility genes and fuelled expectations about opportunities of genetic profiling for personalising medicine. One of the challenges of the next decades is to translate these findings into clinical practice.
In the M.Sc. "Clinical and Genetic Epidemiology for Professionals" (CGEpi) students learn the necessary strategies to perform this translation.
After accomplishing the master program, students will have the ability to:
Students will benefit from the LMU’s long lasting partnerships, providing a wide range of research opportunities.